top of page

Products /  ICU / Efferon NEO

EFFERON

Efferon NEO

Paediatric cytokine adsorption for hyperinflammation

A paediatric blood purification cartridge designed exclusively for children, targeting the broad cytokine cascade seen in hyperinflammatory states.

  • Exclusively for paediatric patients

  • Low-volume design for paediatric circuits

  • Single-use, sterile cartridge

OVERVIEW

About this product

Efferon NEO is specifically designed and approved for paediatric patients. It is not an adult cartridge. Its compact format and low extracorporeal volume support blood purification in children whose deterioration is driven by a generalised inflammatory mediator load.

Its sorbent adsorbs a broad band of cytokines and other mid-molecular-weight molecules implicated in paediatric cytokine storm, hyperinflammatory syndromes and post-cardiotomy inflammatory response.

The cartridge is used in a paediatric extracorporeal circuit and may be run in series with continuous renal replacement therapy, allowing a single circuit to provide both solute clearance and mediator adsorption. Treatment must follow the paediatric instructions for use and local specialist protocol.

PRODUCT DETAILS

Family

ICU

Supplier

Efferon

Availability

Australia & New Zealand

FEATURES

Key features and benefits
Broad cytokine adsorption

Captures a wide band of mid-molecular-weight inflammatory mediators rather than a single target.

CRRT-compatible

Can be placed in series with paediatric renal replacement therapy to combine solute clearance and mediator removal.

Stable haemodynamics

Adsorption avoids the large fluid shifts associated with high-volume exchange techniques.

Paediatric circuit design

A compact cartridge format supports the low extracorporeal volumes required for children.

CLINICAL USE

Applications and indications
Paediatric hyperinflammatory shock

Children with escalating vasopressor requirement and markedly raised inflammatory markers.

Paediatric post-cardiotomy inflammation

Systemic inflammatory response in children following cardiopulmonary bypass.

Other paediatric hyperinflammatory states

Selected non-infective hyperinflammatory conditions in children under specialist direction.

PAEDIATRIC CYTOKINE STORM

PAEDIATRIC HYPERINFLAMMATION

PAEDIATRIC MULTI-ORGAN DYSFUNCTION

SPECIFICATION

Specifications, sizes and models
Therapy

Haemoperfusion — selective adsorption

Target molecules

Endotoxin (LPS) and inflammatory mediators

Patient group

Paediatric patients only — not for adult use

Anticoagulation

Heparin or regional citrate per unit protocol

Use

Single use, sterile, single patient

AVAILABLE SIZES & MODELS

Paediatric cartridge

Compact, low-volume format designed specifically for children

Paediatric series configuration

Pre- or post-filter placement with paediatric CRRT

TECHNICAL

Important technical information
  • Efferon NEO is for paediatric patients only and must not be presented or used as an adult cartridge.

  • Follow the specified priming protocol; incomplete priming can trap air in the sorbent bed.

  • When run in series with CRRT, confirm circuit pressure limits before starting therapy.

  • Monitor for adsorption of therapeutic drugs such as antimicrobials and adjust dosing with pharmacy input.

  • Track platelet count and circuit pressures throughout the session.

RESOURCES

Instructions for use

Supplied with every cartridge

Clinical evidence pack

Published studies collated by our team

ICU in-service training

Delivered on site before first use

ACCESSORIES

  • Blood line set

  • CRRT platform

  • Circuit priming solution

This page is a clinical summary for healthcare professionals. Always refer to the manufacturer's instructions for use for full indications, contraindications, warnings and handling requirements.

bottom of page